– 
Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Pharmalot
Should Pfizer Execs Get Big Merger Bonuses?
Not when thousands of employees lose their jobs. Give me a break! Full Article at Pharmalot
Related Articles
-
Merck and Schering-Plough said Thursday they have won merger approval from the Federal Trade Commission and antitrust regulators in Switzerland and Canada. Merck hopes to close its $41.1 billion acquisition of Schering-Plough before the end of the year. Full Article at Dealbook
-
Now that the merger between Pfizer (PFE) and Wyeth (old ticker WYE) is completed, Pfizer’s compensation committee has agreed to reward two Pfizer executives for their “extraordinary efforts and…extraordinary contributions in addressing critical... Full Article at Footnoted
-
For their work on acquiring and planning to integrate Wyeth, Pfizer cfo and senior vp Frank D’Amelio (pictured left) and Ian Read, senior vp and group president of the biopharma biz (pictured below), were awarded big prizes. Full Article at Pharmalot
-
-- Get a feel for the current M&A landscape: learn what drives acquisition strategies for top companies -- and how other organizations seek suitors for their own sales. Full Article at Freshnews.com
Related Quotes
-
Pressure from both sides of a deal drives the merger activity we're seeing ... Larger companies make acquisitions to position themselves in certain markets and to prepare for patent expirations. A lot of smaller and startup companies, meanwhile, face tremendous financial pressure as operating capital dw...
-
In some ways, mega-deals like this one create more questions than answers
-
We have some really exciting late-stage products
SOURCE: Philadelphia Inquirer -
I've seen a great deal of evidence that Pfizer intends to make the new company a newer and better Pfizer, as opposed to the old Pfizer with some additional products
SOURCE: Philadelphia Inquirer
